Glenmark Pharmaceuticals reports consolidated net profit of Rs 4.38 crore in Q4

26 May 2025 Evaluate

Glenmark Pharmaceuticals has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported 96.80% fall in its net profit at Rs 147.76 crore for the quarter under review as compared to Rs 4,613.70 crore for the same quarter in the previous year. The total income of the company decreased by 28.51% at Rs 2097.95 crore for Q4FY25 as compared to Rs 2,934.49 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported a net profit at Rs 4.38 crore for fourth quarter ended March 31, 2025 as compared to a net loss at Rs 1,238.65 crore for the same quarter in the previous year. However, total income of the company decreased by 14.81% at Rs 3,267.89 crore for Q4FY25 as compared to Rs 3,836.12 crore for the corresponding quarter previous year.

For the year ended March 31, 2025, the company has reported 68.84% fall in its net profit at Rs 1,610.35 crore as compared to Rs 5,167.29 crore for the previous year. However, total income of the company increased by 5.78% at Rs 9,582.78 crore for year under review as compared to Rs 9,059.14 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported a net profit at Rs 1,047.14 crore as compared to a net loss at Rs 1,830.85 crore for the previous year. The total income of the company increased by 6.18% at Rs 13,435.46 crore for year under review as compared to Rs 12,653.09 crore for year ended March 31, 2024.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×